P

Perinatal HIV Research Unit (PHRU) | Soweto ACTG CRS

Research site
(Unclaimed)
Location
Chris Hani Baragwanath Academic Hospital Chris Hani Road, Diepkloof, Soweto, Johannesburg, Johannesburg, South Africa
Site insights

Top conditions

Tuberculosis (3 trials)

Hepatitis B (2 trials)

Chronic Hepatitis B (1 trial)

Multidrug-Resistant Tuberculosis (1 trial)

Infections (1 trial)

Top treatments

Isoniazid
DLM
Delamanid
Selgantolimod
Rifapentine
INH
Pitavastatin

Parent organization

This site is a part of Perinatal HIV Research Unit (PHRU)

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

The purpose of this study is to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations living with HIV: prior HBV vac...

Active, not recruiting
HIV Infection
Hepatitis B
Biological: HEPLISAV-B
Biological: ENGERIX-B

The purpose of this study is to compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing conf...

Enrolling
Tuberculosis, MDR
Drug: Delamanid (DLM)
Dietary Supplement: Pyridoxine (vitamin B6)

Trial sponsors

National Institute of Allergy and Infectious Diseases (NIAID) logo

National Institute of Allergy and Infectious Diseases (NIAID) (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems